Beneficiaries in these states, which include residents of New York, Illinois, and Ohio, can only access GLP-1s like Ozempic, Mounjaro, or Rybelsus if they have a Type 2 diabetes diagnosis
Now in open beta and open to new members
Key details Compounded GLP-1s Semaglutide injections Semaglutide oral tablets Tirzepatide injections Semaglutide oral drops Semaglutide microdoses Tirzepatide oral tablets Tirzepatide oral drops Tirzepatide microdoses Willow does not accept insurance payments for any of its treatment plans
Hansoh will retain control over HS-10535 in China, where it can choose to co-promote or solely commercialize the product
Higher concentration supports smaller injection volumes during research dosing
Safety Considerations L-carnitine is generally well-tolerated, with occasional digestive discomfort at higher doses